Lea M. Beaulieu

2.3k total citations
23 papers, 1.8k citations indexed

About

Lea M. Beaulieu is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Lea M. Beaulieu has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Lea M. Beaulieu's work include Platelet Disorders and Treatments (11 papers), Cancer-related molecular mechanisms research (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Lea M. Beaulieu is often cited by papers focused on Platelet Disorders and Treatments (11 papers), Cancer-related molecular mechanisms research (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Lea M. Beaulieu collaborates with scholars based in United States, Poland and South Korea. Lea M. Beaulieu's co-authors include Jane E. Freedman, Frank Church, Olga Vitseva, Kahraman Tanrıverdi, James A. Huntington, Jill C. Rau, Eric Mick, Elaine Y. Lin, Milka Koupenova and Emelia J. Benjamin and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Lea M. Beaulieu

23 papers receiving 1.7k citations

Peers

Lea M. Beaulieu

HEMAT

IMMUN

ONCOL

Karl Seeger Germany

T M McIntyre United States

Rachel E. Simmonds United Kingdom

Peter A. von dem Borne Netherlands

Marguerite S. Buzza United States

VW van Hinsbergh Netherlands

Sachiko Kanaji United States

Yuan Kong China

Klaus Rieneck Denmark

Estelle S. Harris United States

Karl Seeger Germany

Lea M. Beaulieu

629 ×0.8

HEMAT

791 ×1.3

431 ×0.9

IMMUN

242 ×0.6

282 ×1.2

ONCOL

Citations per year, relative to Lea M. Beaulieu Lea M. Beaulieu (= 1×) peers Karl Seeger

Countries citing papers authored by Lea M. Beaulieu

Since Specialization

Citations

This map shows the geographic impact of Lea M. Beaulieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea M. Beaulieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea M. Beaulieu more than expected).

Fields of papers citing papers by Lea M. Beaulieu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea M. Beaulieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea M. Beaulieu. The network helps show where Lea M. Beaulieu may publish in the future.

Co-authorship network of co-authors of Lea M. Beaulieu

This figure shows the co-authorship network connecting the top 25 collaborators of Lea M. Beaulieu. A scholar is included among the top collaborators of Lea M. Beaulieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea M. Beaulieu. Lea M. Beaulieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beaulieu, Lea M., Kahraman Tanrıverdi, Jane E. Freedman, & Lauren Clancy. (2017). The role of RNA uptake in platelet heterogeneity. Thrombosis and Haemostasis. 117(5). 948–961. 65 indexed citations

Sladojević, Nikola, Goo Taeg Oh, Lea M. Beaulieu, et al.. (2017). Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets. Cardiovascular Research. 113(11). 1307–1317. 23 indexed citations

Thon, Jonathan N., Brad Dykstra, & Lea M. Beaulieu. (2017). Platelet bioreactor: accelerated evolution of design and manufacture. Platelets. 28(5). 472–477. 39 indexed citations

Beaulieu, Lea M., Olga Vitseva, Kahraman Tanrıverdi, et al.. (2016). Platelet functional and transcriptional changes induced by intralipid infusion. Thrombosis and Haemostasis. 115(6). 1147–1156. 6 indexed citations

Freedman, Jane E., Mark Gerstein, Eric Mick, et al.. (2016). Diverse human extracellular RNAs are widely detected in human plasma. Nature Communications. 7(1). 11106–11106. 166 indexed citations

Beaulieu, Lea M., Lauren Clancy, Kahraman Tanrıverdi, et al.. (2015). Specific Inflammatory Stimuli Lead to Distinct Platelet Responses in Mice and Humans. PLoS ONE. 10(7). e0131688–e0131688. 7 indexed citations

Kramer, Carolyn D., Ellen O. Weinberg, Adam C. Gower, et al.. (2014). Distinct gene signatures in aortic tissue from ApoE-/-mice exposed to pathogens or Western diet. BMC Genomics. 15(1). 1176–1176. 9 indexed citations

Beaulieu, Lea M., Elaine Y. Lin, Eric Mick, et al.. (2014). Interleukin 1 Receptor 1 and Interleukin 1β Regulate Megakaryocyte Maturation, Platelet Activation, and Transcript Profile During Inflammation in Mice and Humans. Arteriosclerosis Thrombosis and Vascular Biology. 34(3). 552–564. 130 indexed citations

McManus, David D., Lea M. Beaulieu, Eric Mick, et al.. (2013). Relationship Among Circulating Inflammatory Proteins, Platelet Gene Expression, and Cardiovascular Risk. Arteriosclerosis Thrombosis and Vascular Biology. 33(11). 2666–2673. 51 indexed citations

10.

Risitano, Antonina, Lea M. Beaulieu, Olga Vitseva, & Jane E. Freedman. (2012). Platelets and platelet-like particles mediate intercellular RNA transfer. Blood. 119(26). 6288–6295. 156 indexed citations

11.

Lin, Elaine Y., Jane E. Freedman, & Lea M. Beaulieu. (2009). Innate Immunity and Toll‐like Receptor Antagonists: A Potential Role in the Treatment of Cardiovascular Diseases. Cardiovascular Therapeutics. 27(2). 117–123. 44 indexed citations

12.

Beaulieu, Lea M. & Jane E. Freedman. (2009). The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes. Thrombosis Research. 125(3). 205–209. 57 indexed citations

13.

Rex, Sybille, Lea M. Beaulieu, Olga Vitseva, et al.. (2009). Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and α-granule release. Thrombosis and Haemostasis. 102(7). 97–110. 90 indexed citations

14.

Chakrabarti, Subrata, Lea M. Beaulieu, Lara Reyelt, Mark D. Iafrati, & Jane E. Freedman. (2009). M118, a novel low-molecular weight heparin with decreased polydispersity leads to enhanced anticoagulant activity and thrombotic occlusion in ApoE knockout mice. Journal of Thrombosis and Thrombolysis. 28(4). 394–400. 3 indexed citations

15.

Beaulieu, Lea M., et al.. (2009). Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction. Experimental Cell Research. 316(3). 314–328. 27 indexed citations

16.

Blair, Price, Sybille Rex, Olga Vitseva, et al.. (2008). Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase. Circulation Research. 104(3). 346–354. 220 indexed citations

17.

Rau, Jill C., Lea M. Beaulieu, James A. Huntington, & Frank Church. (2007). Serpins in thrombosis, hemostasis and fibrinolysis. Journal of Thrombosis and Haemostasis. 5. 102–115. 244 indexed citations

18.

Beaulieu, Lea M., Theodore F. Wiesner, Sophie Réhault‐Godbert, et al.. (2007). Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor‐1 cycle. BioEssays. 29(10). 1029–1038. 32 indexed citations

19.

Beaulieu, Lea M. & Frank Church. (2006). Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1. Experimental Cell Research. 313(4). 677–687. 55 indexed citations

20.

Beaulieu, Lea M., et al.. (2006). Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Gynecologic Oncology. 104(2). 470–479. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact